Direct evidence that Ataxin-2 is a translational activator mediating cytoplasmic polyadenylation
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (47) , 15810-15825
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JSPS). (JP17H03635)
- Japan Agency for Medical Research and Development (JP17fk0310111)
- Takeda Science Foundation (JOSEI32912)
This publication has 57 references indexed in Scilit:
- A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1Genes & Development, 2016
- Destabilization of microRNAs in human cells by 3′ deadenylation mediated by PARN and CUGBP1Nucleic Acids Research, 2015
- Specificity factors in cytoplasmic polyadenylationWIREs RNA, 2013
- Anti‐proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylaseThe EMBO Journal, 2011
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational controlNature Cell Biology, 2010
- Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylasesGenes & Development, 2007
- Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomesHuman Molecular Genetics, 2006
- A newly identified N‐terminal amino acid sequence of human eIF4G binds poly(A)‐binding protein and functions in poly(A)‐dependent translationThe EMBO Journal, 1998
- Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2Nature Genetics, 1996